Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
Document Type
Article
Publication Date
2024
Identifier
DOI: 10.1007/978-1-0716-3541-4_1
Abstract
Mass spectrometry (MS) coupled with liquid chromatography (LC) or gas chromatography (GC) has been proven to be a powerful platform in research and specialized clinical laboratories for decades. In clinical laboratories, it is used for compound identification and quantification. Due to the ability to provide specific identification, high sensitivity, and simultaneous analysis of multiple analytes (>100) in recent years, application of MS in routine clinical laboratories has increased significantly. Although MS is used in many laboratory areas, therapeutic drug monitoring, drugs of abuse, and clinical toxicology remain the primary focuses of the field. Due to rapid increase in the number of prescription drugs and drugs of abuse (e.g., novel psychoactive substances), clinical laboratories are challenged with developing new MS assays to meet the clinical needs of the patients. We are here to present "off-the-shelf" and "ready-to-use" protocols of recent developments in new assays to help the clinical laboratory community adopt the technology and analysis for the betterment of patient care.
Journal Title
Methods in molecular biology (Clifton, N.J.)
Volume
2737
First Page
1
Last Page
13
Keywords
Clinical laboratory; Drugs; Gas chromatography; Immunoassays; Liquid chromatography; Mass spectrometry; Tandem mass spectrometry; Therapeutic drug monitoring; Time of flight; Toxicology
Recommended Citation
Victoria Zhang Y, Garg U. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology. Methods Mol Biol. 2024;2737:1-13. doi:10.1007/978-1-0716-3541-4_1